Leadership Overview
Precision Medicine Group has 9 executives leading key functions including strategy, finance, technology, operations, human resources, administration, and clinical solutions.
Driven by a commitment to innovation, Precision Medicine Group empowers pharmaceutical and life-sciences clients to navigate complex product development and commercialization landscapes through an integrated team of experts.
Driven by a commitment to innovation, Precision Medicine Group empowers pharmaceutical and life-sciences clients to navigate complex product development and commercialization landscapes through an integrated team of experts.
Leadership Roles at Precision Medicine Group
Margaret Keegan - Chief Executive Officer
Margaret Keegan, the Chief Executive Officer at Precision Medicine Group, directs the overarching strategy and operational execution for the organization. Keegan guides the company's mission to assist pharmaceutical and life-sciences clients in overcoming product development and commercialization hurdles within a dynamic market. This leadership involves aligning the integrated team of experts across advanced lab sciences, translational informatics, regulatory affairs, payer insights, and marketing communications to deliver comprehensive solutions. Keegan's focus ensures the company maintains its position as a vital partner for clients navigating complex industry challenges. The Chief Executive Officer's role is central to fostering innovation and driving the successful delivery of services that address critical needs in the life sciences sector. By setting the strategic vision, Margaret Keegan ensures the company's continued growth and impact in the market.
Mark Clein - Co-Founder & Chief Executive Officer
Mark Clein, the Co-Founder & Chief Executive Officer at Precision Medicine Group, spearheads the company's strategic direction and foundational growth initiatives. Clein's leadership is integral to establishing and advancing the firm's integrated approach, combining expertise in advanced lab sciences, translational informatics, regulatory affairs, payer insights, and marketing communications. This dual role emphasizes both the entrepreneurial spirit of the company's inception and its ongoing executive management. Clein drives the company's commitment to helping pharmaceutical and life-sciences clients conquer product development and commercialization challenges. The Chief Executive Officer's oversight ensures that the diverse team of experts collaborates effectively to deliver impactful solutions. Mark Clein's vision continues to shape the company's trajectory in a rapidly evolving environment.
Marcus Brown - Vice President, Chief of Staff To the Chief Executive Officer
Marcus Brown, the Vice President, Chief of Staff To the Chief Executive Officer at Precision Medicine Group, provides strategic support and operational coordination for the CEO. Brown facilitates the execution of key initiatives, manages cross-functional projects, and ensures alignment across the leadership team. This role is essential for optimizing the efficiency of the executive office and driving forward the company's strategic objectives. The Vice President, Chief of Staff's responsibilities include streamlining communication, preparing executive materials, and overseeing special projects that advance the company's mission. Marcus Brown's support enables the Chief Executive Officer to focus on high-level strategy and client engagement, ensuring seamless operations within the organization.
Karl Deonanan - Chief Financial Officer
Karl Deonanan, the Chief Financial Officer at Precision Medicine Group, manages the company's financial health and strategic fiscal planning. Deonanan oversees all financial operations, including budgeting, forecasting, and resource allocation, ensuring robust financial stewardship across the organization. This role is critical in supporting the company's mission to provide development and commercialization services for pharmaceutical and life-sciences clients. The Chief Financial Officer's expertise ensures that financial strategies align with the company's growth objectives and operational demands. By maintaining financial integrity, Deonanan enables Precision Medicine Group to invest in its integrated team of experts and advanced capabilities. Karl Deonanan's leadership ensures the financial stability required to address complex product development and commercialization challenges for clients.
Michael Winston - Translational Sciences Chief Operating Officer & Chief Financial Officer
Michael Winston, the Translational Sciences Chief Operating Officer & Chief Financial Officer at Precision Medicine Group, manages critical operational and financial functions within the translational sciences division. Winston oversees the execution of scientific initiatives and ensures financial discipline across these specialized areas. This dual role highlights a comprehensive approach to managing both the scientific progress and the fiscal health of translational science projects. The Chief Operating Officer & Chief Financial Officer's oversight is vital for supporting the company's mission to assist pharmaceutical and life-sciences clients. Michael Winston's leadership ensures that translational science operations are efficient, effective, and financially sound, directly contributing to client success in product development.
Chad Clarke - President
Chad Clarke, the President at Precision Medicine Group, drives operational excellence and strategic growth across the organization. Clarke's leadership focuses on enhancing the delivery of development and commercialization services to pharmaceutical and life-sciences clients. This role involves overseeing key business units and ensuring seamless collaboration among the company's diverse expert teams. The President's responsibilities include fostering client relationships and identifying new opportunities for service expansion. Chad Clarke's strategic oversight is crucial for maintaining the company's competitive edge and ensuring client satisfaction in a rapidly evolving market. Clarke's commitment to operational efficiency supports the company's mission to conquer product development challenges.
Othniel Badea - Chief Technology Officer
Othniel Badea, the Chief Technology Officer at Precision Medicine Group, directs the company's technological infrastructure and innovation strategy. Badea oversees the integration of advanced informatics and digital solutions that support the firm's comprehensive services for pharmaceutical and life-sciences clients. This leadership ensures that the company leverages cutting-edge technology to enhance product development and commercialization efforts. The Chief Technology Officer's responsibilities include managing data science initiatives, ensuring cybersecurity, and driving the adoption of new technological advancements. Badea's focus on technological excellence empowers the integrated team of experts to deliver data-driven insights and efficient solutions. Othniel Badea's strategic technology vision is crucial for navigating the evolving landscape of life sciences.
Tracey Leahy - Chief People Officer
Tracey Leahy, the Chief People Officer at Precision Medicine Group, leads human resources strategy and talent management initiatives. Leahy is responsible for cultivating a high-performing organizational culture, overseeing recruitment, employee development, and compensation strategies. This role is fundamental to building and retaining the integrated team of experts that drives the company's success. The Chief People Officer's focus ensures that Precision Medicine Group attracts and retains top talent across all specialized fields, from lab sciences to informatics and regulatory affairs. Tracey Leahy's leadership in people operations is critical for supporting the company's mission to deliver exceptional services to pharmaceutical and life-sciences clients.
David Winn - Chief Administrative Officer, Clinical Solutions
David Winn, the Chief Administrative Officer, Clinical Solutions at Precision Medicine Group, directs administrative operations and strategic initiatives within the clinical solutions division. Winn ensures the efficient management of resources and processes that support the delivery of clinical services to clients. This role is vital for optimizing the operational framework that enables the company to assist pharmaceutical and life-sciences clients effectively. The Chief Administrative Officer's responsibilities include overseeing departmental functions, managing vendor relationships, and implementing administrative policies that enhance productivity. David Winn's leadership ensures that clinical solution operations are streamlined and aligned with the company's overall mission to address product development challenges.
Explore Leadership Teams in Business Services
Legends Global is the premier partner to the world's greatest live events, venues, and brands. Headquartered in Los Angeles, California, the company is a worldwide venue management group which manages convention centers, music venues, and sports venues. Building on Legends' acquisition of ASM Global in August 2024, the company delivers an unrivaled, fully integrated solution of premium services with a white-label approach. The comprehensive services of Legends Global cover the entire lifecycle of venues and events: feasibility and consulting, owner's representation, sales, partnerships, venue management, hospitality, merchandise, and content and booking. Its network encompasses more than 450 venues worldwide, hosting 20,000 events and entertaining over 165 million guests annually across sports, music, entertainment, attractions, and conventions and leisure. Legends Global is partnered with many of the world's most prominent venues, teams, and properties including Real Madrid, SoFi Stadium in Los Angeles, Dallas Cowboys, New York Yankees, FC Barcelona, Chelsea FC, University of Notre Dame, Ryder Cup, ICC Sydney Convention Center, Caesars Superdome in New Orleans, Avicii Arena in Stockholm, Coca-Cola Arena in Dubai, OVO Arena Wembley in London, Soldier Field in Chicago, AO Arena in Manchester, Moscone Convention Center in San Francisco, and Kai Tak Sports Park in Hong Kong, along with global leagues and properties including LA28 Olympics, NFL, MLB, NASCAR, and PGA of America. The company is committed to becoming the most tech-forward, data-rich business in the sports and entertainment industry, leveraging emerging technologies to create next-generation fan experiences.
Company Leadership
BA
Founded in the early 2000s and headquartered in St. Louis, Missouri, Lumeris Inc is a value-based care managed services operator for health systems and providers. Lumeris aligns providers and payers across populations with technologies, processes, behaviors, and information to achieve cost-effective care with consumers and physicians.
Company Leadership
JC
Ventra Health (formerly DuvaSawko, abeo, & Gottlieb) is a leading healthcare organization focused on tech-enabled revenue cycle management, practice management, and advisory solutions for hospital-based physicians. Ventra partners with private practices, hospitals, health systems, and physician management organizations to deliver market-leading solutions that solve healthcare providers' most complex revenue and reimbursement issues. The company is headquartered in Dallas, Texas.
Company Leadership
LB
SG
Acclime is the premier corporate services provider in Asia, operating in ten key Asian jurisdictions including mainland China, Hong Kong, Malaysia, Cambodia, Vietnam, Philippines, Indonesia, Australia, Thailand and Singapore. Acclime also has client representative offices in the Netherlands, the United Kingdom and the United States of America. The company's vision is to reinvent the corporate services sector with innovative solutions that help corporate and private clients to advance their businesses and interests in difficult-to-navigate markets in emerging Asia.
Company Leadership EP
Frequently Asked Questions Regarding Precision Medicine Group Top Executives and Leadership Team
